Skip to main content
HCPCS J1010 · Level II · Part B drug

J1010: methylprednisolone acetate (Depo-Medrol), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J1010

Billing unit
1 MG
Inj, methylpred acetate 1 mg
ASP payment limit
$0.123
October 2026; +5.1% vs July 2026
Practitioner MUE
160
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
2
8 states

TL;DR

HCPCS J1010 is the Level II code for Injection, methylprednisolone acetate, 1 mg, billed per 1 MG. The Medicare Part B ASP payment limit for October 2026 is $0.123 per billing unit, up 5.1% from July 2026. The practitioner MUE allows up to 160 units per date of service (MAI 3), so a full 160-unit day is $19.68 at the current limit. Under OPPS it carries status indicator N. With a 1 mg billing unit, a single administration can be hundreds of units; the unit count on the claim must equal the milligrams given, and rounding rules for partial units follow the contractor's guidance. The ASP crosswalk maps 42 NDCs to it, sold as Depo-Medrol, Methylprednisolone Acetate by Pfizer Inc, Sandoz Inc., Sagent Pharmaceuticals. 2 Medicare coverage articles list the code across 5 states plus DC and 2 territories, including A57114.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J1010 at $0.123 per 1 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.117 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J1010
QuarterPayment limitPerCoinsurance
October 2026$0.1231 MG20%
July 2026$0.1171 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 42 NDCs from 7 labelers to J1010. Report the NDC in the claim's drug segment and bill the number of J1010 units that equals the quantity administered divided by 1 MG; the last column gives units per full package.

NDCs that crosswalk to J1010
NDCDrug nameLabelerPackage sizeBilling units / package
00009-0274-01Depo-MedrolPfizer Inc5 × 1100
00009-0280-02Depo-MedrolPfizer Inc5 × 1200
00009-0280-03Depo-MedrolPfizer Inc10 × 1400
00009-0280-51Depo-MedrolPfizer Inc5 × 255000
00009-0280-52Depo-MedrolPfizer Inc10 × 2510000
00009-0306-02Depo-MedrolPfizer Inc5 × 1400
00009-0306-12Depo-MedrolPfizer Inc5 × 2510000
00009-3073-01Depo-MedrolPfizer Inc1 × 140
00009-3073-03Depo-MedrolPfizer Inc1 × 251000
00009-3073-22Depo-MedrolPfizer Inc1 × 140
00009-3073-23Depo-MedrolPfizer Inc1 × 251000
00009-3475-01Depo-MedrolPfizer Inc1 × 180
00009-3475-03Depo-MedrolPfizer Inc1 × 252000
00781-3516-75Methylprednisolone AcetateSandoz Inc.5 × 1400
00781-3522-70Methylprednisolone AcetateSandoz Inc.10 × 1400
00781-3522-75Methylprednisolone AcetateSandoz Inc.5 × 1200
25021-0820-05Methylprednisolone AcetateSagent Pharmaceuticals5 × 1200
25021-0820-10Methylprednisolone AcetateSagent Pharmaceuticals10 × 1400
25021-0821-05Methylprednisolone AcetateSagent Pharmaceuticals5 × 1400
42023-0238-01Methylprednisolone AcetateEndo USA, Inc.5 × 1200
42023-0239-01Methylprednisolone AcetateEndo USA, Inc.10 × 1400
42023-0240-01Methylprednisolone AcetateEndo USA, Inc.5 × 1400
50090-0436-00Depo-MedrolA-S Medication Solutions1 × 180
50090-0556-00Depo-MedrolA-S Medication Solutions10 × 1400
50090-1823-00Depo-MedrolA-S Medication Solutions5 × 1400
50090-2098-00Depo-MedrolA-S Medication Solutions1 × 140
50090-5894-00Methylprednisolone AcetateA-S Medication Solutions1 × 140
50090-6024-00Methylprednisolone AcetateA-S Medication Solutions1 × 252000
55150-0313-01Methylprednisolone AcetateEugia US LLC10 × 1400
60219-1573-01Methylprednisolone AcetateAmneal Pharmaceuticals, LLC1 × 140
60219-1573-05Methylprednisolone AcetateAmneal Pharmaceuticals, LLC1 × 251000
60219-1574-01Methylprednisolone AcetateAmneal Pharmaceuticals, LLC1 × 180
60219-1574-05Methylprednisolone AcetateAmneal Pharmaceuticals, LLC1 × 252000
70121-1552-05Methylprednisolone AcetateAmneal Pharmaceuticals, LLC1 × 252000
70121-1573-01Methylprednisolone AcetateAmneal Pharmaceuticals, LLC1 × 140
70121-1573-05Methylprednisolone AcetateAmneal Pharmaceuticals, LLC1 × 251000
70121-1574-01Methylprednisolone AcetateAmneal Pharmaceuticals, LLC1 × 180
70121-1574-05Methylprednisolone AcetateAmneal Pharmaceuticals, LLC1 × 252000
70121-1609-01Methylprednisolone AcetateAmneal Pharmaceuticals, LLC10 × 1400
70121-1609-05Methylprednisolone AcetateAmneal Pharmaceuticals, LLC10 × 2510000
70121-1610-01Methylprednisolone AcetateAmneal Pharmaceuticals, LLC5 × 1400
70121-1610-05Methylprednisolone AcetateAmneal Pharmaceuticals, LLC5 × 2510000

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J1010. For practitioners the limit is 160 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J1010 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services1603 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital1603 Date of Service Edit: ClinicalPrescribing Information
DME supplier1603 Date of Service Edit: ClinicalPrescribing Information

MUE for J1010 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J1010 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J1010 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J1010 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

2 current Medicare Administrative Contractor articles list J1010 in their HCPCS tables, covering 8 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J1010
ArticleTitleContractor(s)StatesRelated LCD
A57114Billing and Coding: Trigger Point InjectionsFirst Coast Service Options, Inc.FL PR VIL33912
A57751Billing and Coding: Trigger Point InjectionsNovitas Solutions, Inc.DC DE MD NJ PAL35010

Diagnoses Medicare contractors cover for J1010

The 2 articles that list J1010 tie their diagnosis groups to other procedure codes, so no covered ICD-10-CM list is attributed to J1010 itself; the diagnosis has to fit the group written for the procedure billed with the drug. See A57114, A57751.

Local coverage policies that list J1010

2 active Local Coverage Determinations list J1010 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J1010 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J1010 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J1010 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J1010

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J1010

What does HCPCS code J1010 describe?

J1010 is defined by CMS as "Injection, methylprednisolone acetate, 1 mg". Each billing unit represents 1 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J1010 a CPT code?

No. J1010 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as methylprednisolone acetate (Depo-Medrol); CPT codes are five-character codes maintained by the AMA. On a Part B claim J1010 reports the drug itself in 1 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J1010 in October 2026?

The ASP-based payment limit is $0.123 per 1 MG, with 20% beneficiary coinsurance. The July 2026 limit was $0.117. Commercial payers use their own fee schedules.

How many units of J1010 can be billed per day?

The practitioner Medically Unlikely Edit is 160 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J1010?

The October 2026 ASP crosswalk lists 42 NDCs from 7 labelers: Depo-Medrol (Pfizer Inc); Methylprednisolone Acetate (Sandoz Inc.); Methylprednisolone Acetate (Sagent Pharmaceuticals); Methylprednisolone Acetate (Endo USA, Inc.). For example NDC 00009-0274-01 (package size 5) equals 100 billing units of J1010.

Does J1010 have NCCI bundling edits?

No active practitioner PTP pairs list J1010 as a column-1 or column-2 code in the v323r0 release.

Which Medicare coverage articles mention J1010?

2 current Billing and Coding Articles in the Medicare Coverage Database list J1010, covering 5 states plus DC and 2 territories: A57114 (Billing and Coding: Trigger Point Injections); A57751 (Billing and Coding: Trigger Point Injections).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.